Latest Shareholder Approval News

EVE Health Group Limited has launched a $1.1 million capital raising via a placement to fund the commercial rollout of its two pharmaceutical products, Dyspro and Libbo. The offer includes shares and options, with some subject to shareholder approval.

Aurumin Limited has sent out its Scheme Booklet detailing the proposed acquisition by Brightstar Resources, setting the stage for shareholder meetings in November. Securityholders are urged to review the materials carefully before voting.

Finbar Group Limited’s 2025 AGM confirmed strong shareholder support for key resolutions as the company reported record sales and unveiled a robust $1.2 billion development pipeline focused on mid-market apartments in Perth.

Biotron Limited is set to acquire Sedarex Limited, gaining global patents for SedRx, a next-generation general anaesthetic, supported by a $2.5 million capital raising to fund regulatory and development milestones.

Bod Science reports a $576k cash outflow in Q1 FY2026 amid ongoing administration and delays in Biortica audit completion. The company plans a shareholder vote in November to approve its acquisition of Biortica and exit from administration.

Saunders International has completed its acquisition of Aqua Metro, a key player in Victoria's water infrastructure sector, marking a strategic expansion into multidisciplinary water projects.

CuFe Ltd has raised $5.4 million through a strategic placement to fund exploration and feasibility studies at its Tennant Creek Copper/Gold project, including a focus on critical mineral bismuth.

Aruma Resources has locked in $3.515 million through a placement to fund targeted exploration across its copper, heavy mineral sands, and uranium projects in Australia. The capital raise, supported by directors and new investors, aims to advance drilling and sampling programs at key sites.

Dalaroo Metals has secured 100% ownership of four gold permits in Côte d’Ivoire, leveraging extensive historical exploration data and planning aggressive drilling to unlock value in a prolific West African gold region.

Skin Elements Limited has locked in $2.5 million through a two-tranche placement to accelerate the commercial rollout of its SE Formula biotechnology products, offering investors discounted shares and options.

Green Critical Minerals is set to issue over 107 million shortfall shares to underwriters following the expiry of its quoted options, marking a significant step in its capital management strategy.

Vital Metals has locked in firm commitments for an extra $5.6 million placement, building on its August raise, to accelerate development of its Tardiff rare earths deposit in Canada.